| Title: |
P-1470. RSV-Related Knowledge, Attitudes, and Practices Among US Primary Care and Specialist Physicians |
| Authors: |
La, Elizabeth M; Gallington, Kyli; Singer, David; Balantac, Zaneta; Eltoukhy, Noha S; Han, Yipin; Bushnell, Donald M |
| Source: |
Open Forum Infectious Diseases ; volume 13, issue Supplement_1 ; ISSN 2328-8957 |
| Publisher Information: |
Oxford University Press (OUP) |
| Publication Year: |
2026 |
| Description: |
Background During the 2024–2025 respiratory syncytial virus (RSV) season in the United States (US), RSV vaccination was recommended by the Advisory Committee on Immunization Practices (ACIP) for all adults aged ≥ 75 years and adults aged 60–74 years at increased risk for severe RSV disease. This study evaluated RSV-related knowledge, attitudes, and practices (KAP) among US healthcare professionals (HCPs), including primary care physicians (PCPs) and specialist physicians. Methods A cross-sectional online survey of RSV-related KAP was administered to US HCPs between December 2024–January 2025. The survey targeted 700 HCPs, including PCPs (n=200), specialists (n=150), nurse practitioners and physician assistants (n=150), and pharmacists (n=200). Descriptive results are presented here on PCPs’ and specialists’ knowledge of adult RSV disease and vaccination, RSV-related attitudes, RSV vaccination practices, and potential vaccination barriers. Results The final sample of 700 HCPs included 199 PCPs and 153 specialists (50 cardiologists, 50 endocrinologists, and 53 pulmonologists). Most PCP and specialist respondents reported being very familiar with RSV disease (83.9% and 80.4%, respectively). At the time of data collection, 81.3% of PCPs and 75.0% of specialists were aware that RSV vaccines were ACIP-recommended among all adults aged ≥ 75 years. However, fewer respondents were aware of the risk-based ACIP recommendation for adults aged 60–74 years (32.8% of PCPs and 27.0% of specialists). Most respondents perceived a benefit of having RSV vaccines available and recommended for all adults aged 60–74 years. Although more than 80% of PCPs and specialists reported recommending RSV vaccines to their eligible patients, these recommendations were not provided to all eligible patients consistently. Patient refusal or hesitancy was the most frequently reported barrier to recommending RSV vaccination to adults aged ≥ 60 years. Conclusion Despite the familiarity of RSV disease among PCPs and specialists, additional ... |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1093/ofid/ofaf695.1656 |
| Availability: |
https://doi.org/10.1093/ofid/ofaf695.1656; https://academic.oup.com/ofid/article-pdf/13/Supplement_1/ofaf695.1656/66353067/ofaf695.1656.pdf |
| Rights: |
https://creativecommons.org/licenses/by/4.0/ |
| Accession Number: |
edsbas.550BC045 |
| Database: |
BASE |